ARGX Snapshot
argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases, hematology and cancer. The company is headquartered in Breda, the Netherlands.
Market Capitalization$19,768,343,000
Price to Sales51.86
Earnings per Share$-11.5300
PE RatioNone
Most Recent Close$364.4700
52 Week High$376.78
52 Week Low$249.5
50-Day Moving Average$318.62
200-Day Moving Average$305.32
All data are from Alpha Vantage as of today. For more infomation on ARGX see Stock Dividend, Valuation, Price and Financial Data for Investors